在成功的导管切除后,心房的分子机制复发
Muhammad Sanusi1, Roopeessh Vempati1, Dinakaran Umashankar1
1Department of Internal Medicine, Trinity Health Oakland/Wayne State University, Pontiac, MI 48341, USA.
Cells
|January 9, 2026
概括
在切除之后,心房的复发是常见的. 本综述探讨了纤维化和炎症等分子因素,强调需要进一步研究以改善治疗结果.
科学领域:
- 心脏病学 心脏病学
- 分子生物学分子生物学
- 医学研究 医学研究
背景情况:
- 心房动 (AF) 是一种普遍的心律失常,导致显著的发病率和死亡率.
- 导管切除是一种关键的治疗方法,但高复发率限制了其有效性.
研究的目的:
- 审查导致AF在导管切除后复发的分子机制.
- 识别知识缺口,并建议未来的研究方向.
主要方法:
- 对AF复发的分子机制的当前文献进行系统审查.
- 综合了与结构改造,离子通道功能,炎症和遗传因素相关的发现.
主要成果:
- 关键途径包括纤维化 (TGF-β1,MMPs),离子通道失调,炎症和自主失衡.
- 遗传和表观遗传因素也会导致AF复发.
- 目前的研究受限于小型,异质的研究和不充分的长期随访.
结论:
- 进一步的研究整合多omics和先进的成像是了解AF复发机制至关重要的.
- 验证TGF-β1,MMP和新型标记物等生物标记物是必不可少的.
- 个性化诊断和治疗策略有望改善AF管理和患者的治疗结果.
相关概念视频
Disturbances in Heart Rhythm
2.5K
Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
2.5K
Mechanism of Cardiac Arrhythmias
1.6K
Arrhythmias are irregular heart rhythms occurring when the heart's electrical impulses become abnormal. These disturbances can lead to various symptoms, depending on their severity and the underlying cause. Some common factors contributing to arrhythmias include hypoxia, ischemia, electrolyte imbalances, excessive catecholamine exposure, drug toxicity, and muscle overstretching. Arrhythmias can be classified into two main types based on the rate and site of origin of abnormal heart rhythms.
1.6K
ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
453
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
453
Dysrhythmias VI: Management of Dysrhythmias
424
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
424
Clot Retraction and Fibrinolysis
8.4K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
8.4K
Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
1.4K
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
1.4K


